Natco Pharma Limited received Order from Hon’ble High Court of Delhi stating that NATCO is allowed to launch Chlorantraniliprole (CTPR) and its formulations, through its non-infringing process.

NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole (CTPR) Technical 93.00% w/w min. under Section 9(3). CTPR technical is formulated into broad-spectrum insecticides used across wide range of crops for pest management.

NATCO estimates the current market size of CTPR containing products in India to be over INR 2000 crores. The Company plans to launch its products very shortly.